| Style | Citing Format |
|---|---|
| MLA | Nazemi P, et al.. "Rechallenge of Polymyxins After Incidence of Neurotoxicity: A Risk or a Second Chance?." American Journal of Therapeutics, vol. 33, no. 1, 2026, pp. e71-e74. |
| APA | Nazemi P, Talebi F, Hedayati Emami K, Jafarieh A, Albaji M, Davoudimonfared E (2026). Rechallenge of Polymyxins After Incidence of Neurotoxicity: A Risk or a Second Chance?. American Journal of Therapeutics, 33(1), e71-e74. |
| Chicago | Nazemi P, Talebi F, Hedayati Emami K, Jafarieh A, Albaji M, Davoudimonfared E. "Rechallenge of Polymyxins After Incidence of Neurotoxicity: A Risk or a Second Chance?." American Journal of Therapeutics 33, no. 1 (2026): e71-e74. |
| Harvard | Nazemi P et al. (2026) 'Rechallenge of Polymyxins After Incidence of Neurotoxicity: A Risk or a Second Chance?', American Journal of Therapeutics, 33(1), pp. e71-e74. |
| Vancouver | Nazemi P, Talebi F, Hedayati Emami K, Jafarieh A, Albaji M, Davoudimonfared E. Rechallenge of Polymyxins After Incidence of Neurotoxicity: A Risk or a Second Chance?. American Journal of Therapeutics. 2026;33(1):e71-e74. |
| BibTex | @article{ author = {Nazemi P and Talebi F and Hedayati Emami K and Jafarieh A and Albaji M and Davoudimonfared E}, title = {Rechallenge of Polymyxins After Incidence of Neurotoxicity: A Risk or a Second Chance?}, journal = {American Journal of Therapeutics}, volume = {33}, number = {1}, pages = {e71-e74}, year = {2026} } |
| RIS | TY - JOUR AU - Nazemi P AU - Talebi F AU - Hedayati Emami K AU - Jafarieh A AU - Albaji M AU - Davoudimonfared E TI - Rechallenge of Polymyxins After Incidence of Neurotoxicity: A Risk or a Second Chance? JO - American Journal of Therapeutics VL - 33 IS - 1 SP - e71 EP - e74 PY - 2026 ER - |